CASI Pharmaceuticals Inc (CASI) — Cash Flow-to-Debt Ratio
CASI Pharmaceuticals Inc (CASI) has a Cash Flow-to-Debt Ratio of -0.03x as of March 2023, meaning its operating cash flow of $-843.00K could theoretically repay 0% of its total liabilities ($26.17 Million) in one year. Explore CASI Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CASI Pharmaceuticals Inc Cash Flow-to-Debt Ratio (1994–2024)
Historical debt coverage capacity for CASI Pharmaceuticals Inc across 31 annual periods. Also explore CASI Pharmaceuticals Inc (CASI) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for CASI Pharmaceuticals Inc (1994–2024)
Year-by-year debt coverage analysis for CASI Pharmaceuticals Inc. For market capitalisation and broader financial context, see CASI market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.56x | $-29.22 Million | $51.82 Million | ▼ -44.3% |
| 2023 | -0.39x | $-19.97 Million | $51.10 Million | ▲ +45.7% |
| 2022 | -0.72x | $-21.09 Million | $29.30 Million | ▲ +18.7% |
| 2021 | -0.88x | $-26.84 Million | $30.34 Million | ▲ +17.4% |
| 2020 | -1.07x | $-25.89 Million | $24.16 Million | ▲ +58.7% |
| 2019 | -2.59x | $-23.24 Million | $8.97 Million | ▲ +64.2% |
| 2018 | -7.24x | $-28.58 Million | $3.95 Million | ▼ -642.0% |
| 2017 | -0.98x | $-6.40 Million | $6.56 Million | ▼ -12.3% |
| 2016 | -0.87x | $-6.02 Million | $6.93 Million | ▼ -87.8% |
| 2015 | -0.46x | $-5.51 Million | $11.91 Million | ▼ -35.9% |
| 2014 | -0.34x | $-4.00 Million | $11.73 Million | ▲ +94.1% |
| 2013 | -5.80x | $-3.28 Million | $565.17K | ▼ -94.6% |
| 2012 | -2.98x | $-2.21 Million | $742.75K | ▲ +50.9% |
| 2011 | -6.07x | $-4.27 Million | $704.09K | ▼ -230.8% |
| 2010 | -1.83x | $-4.96 Million | $2.70 Million | ▼ -115.4% |
| 2009 | -0.85x | $-10.21 Million | $11.99 Million | ▲ +5.4% |
| 2008 | -0.90x | $-20.71 Million | $23.00 Million | ▲ +0.0% |
| 2007 | -0.90x | $-23.52 Million | $26.12 Million | ▲ +62.1% |
| 2006 | -2.38x | $-20.77 Million | $8.74 Million | ▼ -15.4% |
| 2005 | -2.06x | $-14.52 Million | $7.05 Million | ▲ +53.8% |
| 2004 | -4.46x | $-16.41 Million | $3.68 Million | ▲ +3.0% |
| 2003 | -4.59x | $-24.25 Million | $5.28 Million | ▼ -74.6% |
| 2002 | -2.63x | $-45.53 Million | $17.30 Million | ▼ -14.5% |
| 2001 | -2.30x | $-52.87 Million | $23.01 Million | ▲ +35.8% |
| 2000 | -3.58x | $-44.25 Million | $12.35 Million | ▲ +1.9% |
| 1999 | -3.65x | $-35.80 Million | $9.80 Million | ▼ -87.0% |
| 1998 | -1.95x | $-12.50 Million | $6.40 Million | ▼ -68.7% |
| 1997 | -1.16x | $-6.60 Million | $5.70 Million | ▼ -236.8% |
| 1996 | -0.34x | $-2.20 Million | $6.40 Million | ▲ +49.7% |
| 1995 | -0.68x | $-4.44 Million | $6.50 Million | ▲ +90.6% |
| 1994 | -7.25x | $-4.35 Million | $600.00K | — |